Introduction: Idiopathic pulmonary fibrosis (IPF) patients suffer increasing functional limitation with disease worsening disease. Increasing time in sedentary behavior has been associated with poorer quality of life. Determining thresholds for activity in patients with respiratory disease is difficult due to variable cardiorespiratory limitations between individuals. Measuring sedentary behavior is not confounded by this limitation and may be a better measurement of activity in patients with respiratory disease.
| I NTR ODU CTI ON
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease (ILD) of unknown cause. 1 Affected lungs show characteristic fibrosis, with progressive impairment of gas transfer leading to exercise-induced dyspnoea 2 and reduced physical activity in daily life. 3 Physical activity is associated with numerous health benefits. 4 However, it is becoming increasingly apparent that prolonged time in sedentary behaviors, inactivity defined as a combination of sitting and low levels of energy expenditure, 5 has negative effects on health even if recommendations on physical activity levels are met. [6] [7] [8] This may be of particular importance in patients with chronic lung diseases, including IPF, where achieving recommended levels of moderate or vigorous physical activity may be unrealistic due to exertional dyspnoea and fatigue.
Daily activity in free-living conditions can be measured over a period of several days using multiaxis accelerometers. The accuracy of these devices to estimate energy expenditure compared with indirect calorimetry or doubly labeled water has been investigated in certain chronic lung diseases 10 but not in patients with interstitial diseases like IPF. However, wristworn accelerometers are also able to measure sedentary behaviors using postural data. 11 In contrast to the difficulties of classifying activity vigour using accelerometer outputs in disease, we hypothesized that the accuracy of measuring sedentary behavior time with these devices should not significantly vary between health and disease. Our rationale for this was that the definition of sedentary behaviors will not alter in patients with chronic disease as the two defining aspects of sedentary behaviors (sitting position and low energy state) should remain unchanged even with marked cardiorespiratory limitation. This study investigates the feasibility of using a wristworn, three-axis accelerometer as a measure of daily physical activity and time in sedentary behaviors in patients with IPF, and evaluates the associations between time spent in sedentary behaviors and lung function, 6-min walk distance (6MWD) and questionnaire measures of dyspnoea, depression and anxiety, fatigue and quality of life, as well as accelerometer outputs for activity levels.
| M E THO DS

| Subjects
Patients with a diagnosis of definite or probable IPF based on high resolution CT criteria, 1 or lung biopsy confirming usual interstitial pneumonia without an alternative cause, were approached in the respiratory clinic at Norfolk and Norwich University Hospital, Norfolk UK. Ethical approval was given by South Central-Oxford C research ethics committee (reference number 13/SC/0116). Patients were excluded if they had significant cardiac or pulmonary disease contributing to their symptoms, respiratory tract infection within 4 weeks of inclusion, significant co-morbid disease that was likely to impact on daily activity, or inability to consent. Forty-eight patients consented to participate. Four patients were subsequently found to have diagnoses other than IPF and five patients withdrew consent before undertaking any assessments. In total, 39 participants underwent clinical assessment and daily activity measurement. All included patients were clinically stable during the measurement period.
| Clinical assessments
Prior to activity measurement, all participants underwent 6MWD, and pulmonary function tests (PFTs). PFTs were performed in the pulmonary function laboratory at the Norfolk and Norwich Hospital (CareFusion Masterscreen PFT system). The results of the forced vital capacity (FVC) and diffusing capacity of carbon monoxide (DLCO) were recorded as a percentage of predicted values. Patients were stratified by disease severity, with severe disease defined as an FVC <55% or DLCO <40%. 12 The 6MWD was performed without supplemental oxygen and in accordance with ATS guidelines. 13 Baseline and minimum saturations during the 6MWD were recorded. Participants completed a number of questionnaires: the MRC dyspnoea scale 14 was performed to determine their severity of dyspnoea, the Hospital Anxiety and Depression Scale (HADS), which is able to identify and quantify two common forms of psychological problems in patients with ILD, 15 the Fatigue Assessment Scale (FAS), 16 and the Kings Brief Interstitial Lung Disease (KBILD) questionnaire. 17 Mortality data for participants was recorded from their hospital records for 24 months following participation.
| Measurement of daily activity
All participants were asked to wear a wrist-worn, tri-axial accelerometer (GENEActiv actiwatch; GENEActiv, Cambridgeshire, UK) on their nondominant wrist continuously for at least seven consecutive days. The sampling frequency of the device was 50 Hz. Data from the devices was defined as valid if there was at least 16 h of data on at least 2 week days and 2 weekend days. 18 Accelerometer data was processed according to acceleration intensity and time in sedentary behavior. Activity data was analysed using the R-statistics package GGIR. 19 Mean acceleration intensity (the single vector magnitude of the combined accelerations in all three axes recorded by the device) in the most active 5-h period in each day was recorded in milli-g units (M5) and averaged across each day of valid wear time. Time in sedentary behavior was calculated by converting raw data from the GENEActiv devices to 15-s epoch files by the GENEActiv PC software and then analysed using a sedentary sphere custom spreadsheet (available from the authors of the original paper 11 ).
| Statistical analysis
Data analysis was undertaken using SPSS Statistics version 22 (IBM Corp, Illinois, USA). Data was divided into terciles by average minutes in sedentary behaviors per day. Comparison of M5 and mean daily time in sedentary behaviors were compared after stratifying IPF severity by lung function values, using FVC <55% predicted or DLCO <40% predicted as per previous trials. 12 Time in sedentary behavior was analyzed by day of the week to investigate differences between weekdays and weekend days. Bivariate analyses between predictor variables (age, FVC% predicted, DLCO% predicted, 6MWD, MRC dyspnoea score, HADS score, KBILD, and FAS) and both M5 values and time in sedentary behaviors were performed. The M5 variable was ATKINS ET AL. | logarithmically-transformed to normalise distribution (other variables were normally distributed). Subsequently, variables with P < .2 in the bivariate analysis were introduced into a multivariate linear regression model with stepwise removal of nonsignificant predictors. Partial r 2 values for significant predictors remaining within the final model were calculated to determine variability explained by each predictor. Mortality data for the 12-and 24-month period following study participation was analysed using the Kaplan-Meier estimator, with survival results displayed for each tercile of time spent in sedentary behaviors.
| R ES ULTS
Of the 39 patients who wore an accelerometer, 35 devices recorded valid data (89.7%). Four devices contained insufficient data to analyse; two devices failed (battery insufficiently charged) and two devices were removed prematurely by participants before sufficient data had been collected.
Demographic and activity data for the participants are shown in Table 1 . No patients were receiving supplemental oxygen at the time of assessment. Eleven patients (31.4%) had severe disease. Exercise tolerance (6MWD) was moderately reduced. HADS scores were higher in the highest two terciles of time in sedentary behaviors. No differences in FAS scores were seen across each tercile and KBILD scores decreased across terciles of increasing time in sedentary behavior suggesting worse health-related quality of life. The most sedentary group spent 195.4 min more time in sedentary behaviors per day on average than the least sedentary group. A trend toward higher accelerometer outputs during the most active 5 h each day was seen, with the most (Figure 1) . No difference in time spent in sedentary behavior was seen between any days of the week (Figure 2 ). The outcomes from the bivariate correlation and the multivariate regression model are shown in Table 2 . None of the clinical measures (lung function, 6MWD or questionnaire results) showed a relationship with time in sedentary behavior. Only M5 values from the accelerometer showed significant correlation with time in sedentary behavior; in the regression analysis this was the only variable that satisfied the requirements for inclusion in the model. This variable was responsible for only 13.4% of the variability in time in sedentary behavior seen (r 2 5 0.134). When predicting physical activity during the most active 5 h, the 6MWD and FVC were the only variables that remained in the regression model, with 23.5% of the variability in the M5 value was predicted by these two variables. Mortality data for the two years following participation in the study is shown in Figure 3 . Six (17.1%) patients died within one year of completing the study. Nine patients (25.7%) died within two years. There was a tendency toward higher mortality in the two most sedentary terciles, although there was no significant statistical difference between the three terciles.
| D ISCU SSI ON
To our knowledge this is the first study to investigate sedentary behaviors in IPF patients using a wrist-worn, three-axis accelerometry devices. The results suggest these devices can feasibly measure time in sedentary behavior and activity over a period of at least seven days in patients with chronic respiratory disease. No difference was seen in duration of 21 Concerns about lack of agreement between waist and wrist accelerometers have been raised, but used appropriately the classification of activity intensity has been shown to be in the same range as those reported for waist-worn devices. 22, 23 Furthermore, only the wrist-worn GENEActiv device has been used so far to measure time in sedentary behaviors. 11, 24 There was a wide spread of time spent in sedentary behaviors in the group. There were insufficient participants in this trial to draw firm conclusions about whether sedentary behaviors influence mortality, but the trend toward increased mortality at both one and two years in the more sedentary participants raises the possibility of an association. Previous studies have shown that people with greater sedentary time have poorer health outcomes. 8 Furthermore, the cohort here appeared relatively sedentary compared to populations of equivalent age. One study measuring sedentary behaviors and monitoring mortality and morbidity in 93,676 women in the United States of America reported that 25.9% of participants aged 70-79, similar to the age range included here, spent less than 4 h per day in sedentary behaviors. 25 In addition, participants spending less than 4 h per day in sedentary behaviors had better outcomes than those spending more than 11 h in sedentary behavior per day (similar to the mean time spent in sedentary behaviors in tercile 3 of our cohort, of 656.7 minutes per day). Reducing sedentary behaviors may be beneficial, but predicting those patients in clinic who are likely to be highly sedentary may be difficult. Furthermore, it will be difficult for patients with severe disease to increase even light activity and is unlikely to affect prognosis in these cases. Furthermore, it will be difficult for patients with severe disease to increase even light activity and is unlikely to affect prognosis in these cases. No clinical measures within this group showed a relationship with time in sedentary behavior, whereas variability in measures of activity (M5) was predicted well by 6MWD; direct assessment of sedentary behaviors in free living using monitoring devices may be required. We deliberately avoided using predetermined thresholds for activity vigour using the GENEActiv devices as these thresholds are likely to vary highly between individual patients depending upon disease severity. The measure of physical activity we chose for analysis was the M5 value; it was felt that this measure would best reflect the peak activity of the subject without being influenced by the relatively longer periods of sleep or sedentary behaviors. Without previous validation with indirect calorimetry or double-labeled water as a comparison in patients with ILDs, the classification of physical activity vigour using these devices may be inaccurate. By contrast, the definition of sedentary behavior should not be significantly different between healthy individuals and patients such as those included in this study, and therefore should be measured equally accurately by the GENEActiv device as when used in healthy volunteers. 11, 24 As a result, the measurement of sedentary time should not need revalidating in this population as the use of accelerometers to define exercise intensity would.
No studies have been performed to validate accelerometers as a measure of physical activity energy expenditure in IPF, although they have been performed in COPD. This showed that the SenseWear Pro armband could accurately measure energy expenditure in metabolic equivalents in laboratory conditions, albeit with a tendency to underestimate energy expenditure when walking and over-estimate when performing daily activities. 10 Studies that have used accelerometers in IPF have used proximally worn devices. 3, 26, 27 Wallaert and colleagues used the SenseWear Pro armband and showed that there was a 45% decrease in exercise expenditure >2.5 metabolic equivalents per day compared with a sedentary healthy population, as well as an association between lower steps per day and increased mortality. 3 Bahmer et al. also used the SenseWear Pro armband to identify that fatigue, alongside 6MWD, were the strongest predictors of activity measured as steps per day. 27 In the paper by Wallaert and colleagues, 6MWD predicted 11% of the variability in number of steps per day, similar to the 13.7% in variability in M5 values explained by 6MWD in our FIGU RE 3 Kaplan Meier plot of 2-year survival probability by tercile of time in sedentary behavior study. Finally, Nakayama et al. used a waist-worn uniaxial accelerometer that had not previously been used in IPF patients, showing that only 70.6 minutes per day were spent performing any activity. This was the only study to describe potentially sedentary behaviors; 611.2 minutes per day were spent at a level of movement too low to measure as activity (<1 magnitude of movement, corresponding with any activity less intense than light activity). 26 Because their device could not determine posture it is impossible to determine whether all of this time was truly sedentary. The time spent at this level of inactivity was slightly higher than observed in our participants (mean time in sedentary behavior per day 551.7 min per day). The difference in time seen may relate to the different demographic studied, although the cohort in our study was older than the Japanese cohort (mean age 75.1 years compared with 68.3 years). Alternatively, inability to wear the waist-worn device at all times may have caused under-recording of time spent performing sedentary behaviors but nonwear time was not reported in the paper. The measurement of sedentary behavior in patients with IPF and other chronic respiratory diseases may become increasingly important. While the difficulty of increasing physical activity to the point of meeting recommended guidelines has been discussed in COPD patients, 9 the same problems affect patients with IPF. Chronic dyspnoea and fatigue limit exercise in this group, 27 and increasing peak exercise to spend more time performing at least moderate exercise may be unreasonable. There is some evidence to suggest that improving time in light activity compared with sedentary behavior, even when not meeting recommended levels of moderate and vigorous intensity exercise, can improve various outcomes in healthy populations 28 ; the benefits of increasing light physical activity and reducing sedentary behaviors in IPF and other chronic diseases warrants further investigation. This study had a number of strengths. The IPF cohort analysed was well-characterised, excluded co-morbidities that may have affected daily activity, and recording anxiety and depression scores. The number of participants providing valid data was high. The use of three-axis, wrist-worn accelerometer was able to provide large amounts of data, with participants wearing the devices for at least 7 days. The results reveal the sedentary behaviors of patients with IPF for the first time. There are also some weaknesses. The small number of participants within this feasibility study limits the ability to conclude whether increased time spent in sedentary behaviors is associated with worse outcomes. Further investigation with larger cohorts will be needed to investigate this association. There was a small range of HADS scores in our sample and therefore we may have underestimated the influence of this outcome on activity. Other factors that may help predict activity and sedentary behaviors, such as motivation and socio-economic factors, were not explored in this group.
In conclusion, the wrist-worn GENEActiv accelerometer can feasibly record sedentary behaviors in IPF patients. IPF patients spent significant periods of their day in sedentary behaviors. Of routine clinical measurements 6MWD was the best predictor of activity. A moderate inverse relationship between activity and sedentary behaviors was seen, but no clinical measurements could predict time in sedentary behavior. Reducing sedentary time spent in and increasing time in light activities may be beneficial in IPF as it may improve outcomes and be a more achievable goal in patients who are markedly limited by their respiratory disease.
